Case Report
Published on 03 Oct 2025
Case Report: Could genetic factors influence the outcomes of first-line enfortumab vedotin plus pembrolizumab therapy in patients with metastatic urothelial carcinoma? Two cases of patients harbouring a BRCA mutation
in Genitourinary Oncology
- 473 views